| 5th May 2021 6:23 pm |
RNS |
Result of AGM |
| 4th May 2021 4:29 pm |
RNS |
Total Voting Rights |
| 28th Apr 2021 5:33 pm |
RNS |
Director/PDMR Shareholding |
| 28th Apr 2021 12:00 pm |
RNS |
1st Quarter Results |
| 26th Apr 2021 4:14 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Apr 2021 3:00 pm |
RNS |
EU approves GSK’s JEMPERLI (dostarlimab-gxly) |
| 23rd Apr 2021 7:00 am |
RNS |
FDA approves GSK’s JEMPERLI (dostarlimab-gxly) |
| 16th Apr 2021 4:00 pm |
RNS |
Director/PDMR Shareholding |
| 15th Apr 2021 3:21 pm |
RNS |
Director/PDMR Shareholding |
| 15th Apr 2021 10:17 am |
RNS |
Director/PDMR Shareholding |
| 14th Apr 2021 2:14 pm |
RNS |
Director/PDMR Shareholding |
| 14th Apr 2021 11:58 am |
RNS |
Director/PDMR Shareholding |
| 12th Apr 2021 5:32 pm |
RNS |
Director/PDMR Shareholding |
| 12th Apr 2021 9:48 am |
RNS |
Director/PDMR Shareholding |
| 9th Apr 2021 5:34 pm |
RNS |
Director/PDMR Shareholding |
| 9th Apr 2021 1:35 pm |
RNS |
Director/PDMR Shareholding |
| 6th Apr 2021 2:30 pm |
RNS |
Directorate Change |
| 1st Apr 2021 3:36 pm |
RNS |
Total Voting Rights |
| 30th Mar 2021 4:21 pm |
RNS |
Publication of 2021 AGM Notice |
| 30th Mar 2021 11:30 am |
RNS |
GSK respiratory product sales reporting changes |
| 24th Mar 2021 12:30 pm |
RNS |
Moncef Slaoui Departs Galvani Bioelectronics |
| 23rd Mar 2021 4:31 pm |
RNS |
Director/PDMR Shareholding |
| 17th Mar 2021 6:24 pm |
RNS |
Chair of Audit & Risk Committee |
| 16th Mar 2021 11:08 am |
RNS |
Medicago and GSK start Phase 3 trial |
| 15th Mar 2021 5:27 pm |
RNS |
Director/PDMR Shareholding |
| 15th Mar 2021 7:00 am |
RNS |
Annual Report 2020 on Form 20-F |
| 11th Mar 2021 2:25 pm |
RNS |
Director/PDMR Shareholding |
| 11th Mar 2021 7:00 am |
RNS |
GSK and Vir share positive VIR-7831 data in COVID |
| 10th Mar 2021 1:23 pm |
RNS |
Director/PDMR Shareholding |
| 9th Mar 2021 1:43 pm |
RNS |
Annual Financial Report |
| 2nd Mar 2021 3:48 pm |
RNS |
Director/PDMR Shareholding |
| 1st Mar 2021 10:55 am |
RNS |
Total Voting Rights |
| 25th Feb 2021 12:00 pm |
RNS |
GSK announces otilimab data for treatment of COVID |
| 24th Feb 2021 1:59 pm |
RNS |
Director/PDMR Shareholding |
| 24th Feb 2021 12:13 pm |
RNS |
Holding(s) in Company |
| 23rd Feb 2021 9:03 am |
RNS |
Director/PDMR Shareholding |
| 22nd Feb 2021 4:39 pm |
RNS |
Director/PDMR Shareholding |
| 22nd Feb 2021 10:40 am |
RNS |
Sanofi and GSK initiate new Phase 2 study |
| 19th Feb 2021 12:52 pm |
RNS |
Director/PDMR Shareholding |
| 19th Feb 2021 12:31 pm |
RNS |
Director/PDMR Shareholding |
